Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I dose escalation safety study of nanoparticulate paclitaxel (CTI 52010) in normal dogs.

International journal of nanomedicine·2011
Same author

Blunted pathogen-associated molecular pattern motif induced TNF, IL-6 and IL-10 production from whole blood in dogs with lymphoma.

Veterinary immunology and immunopathology·2011
Same author

Hematologic changes associated with half-body irradiation in dogs with lymphoma.

Journal of veterinary internal medicine·2006
Same author

What is your diagnosis? Spindle cell sarcoma .

Journal of the American Veterinary Medical Association·2006

Related Experiment Video

Updated: May 12, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Canine prostatic carcinoma.

Sandra M Axiak1, Astrid Bigio

  • 1University of Missouri, USA.

Compendium (Yardley, PA)
|March 28, 2013
PubMed
Summary

Canine prostatic carcinoma is aggressive and spreads to other organs. Enlarged, mineralized prostates in castrated dogs may indicate this cancer, requiring multimodal treatment for better quality of life.

Area of Science:

  • Veterinary oncology
  • Canine cancer research

Background:

  • Canine prostatic carcinoma is a locally aggressive cancer.
  • It has a high propensity for metastasis to lymph nodes, lungs, liver, spleen, and bone.

Purpose of the Study:

  • To review the staging and treatment of canine prostatic carcinoma.
  • To highlight key diagnostic findings and therapeutic considerations.

Main Methods:

  • Review of current literature on canine prostatic carcinoma.
  • Discussion of diagnostic imaging modalities (radiography, ultrasonography).
  • Overview of treatment strategies including NSAIDs and other therapies.

Main Results:

  • Common metastatic sites are well-defined.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Experiment Videos

Last Updated: May 12, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

  • Prostatic enlargement and mineralization in castrated males are significant indicators.
  • NSAIDs are crucial for pain management.
  • Conclusions:

    • Accurate staging is essential for treatment planning.
    • Multimodal therapeutic approaches are necessary to improve patient quality of life.
    • Early identification of canine prostatic carcinoma improves prognosis.